Cardinal Health (NYSE:CAH) Stock Gets Price Target Bump from Wells Fargo & Company

Cardinal Health (NYSE:CAH – Get Free Report) had its price target raised by analysts at Wells Fargo & Company from $277.00 to $321.00 in a report released on Tuesday, Benzinga reports. The firm presently has an “overweight” rating on the stock. Wells Fargo & Company‘s price objective would indicate a potential upside of 13.05% from the company’s previous close.

Several other research analysts have also recently issued reports on the stock. Wall Street Zen upgraded shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a report on Sunday, October 25th. Mizuho set a $290.00 price objective on shares of Cardinal Health in a research note on Thursday, November 5th. Robert W. Baird upped their price target on Cardinal Health from $251.00 to $274.00 and gave the company an “outperform” rating in a report on Wednesday, August 12th. JPMorgan Chase & Co. raised their price objective on Cardinal Health from $260.00 to $286.00 and gave the stock a “neutral” rating in a research note on Tuesday, November 10th. Finally, TD Cowen upped their target price on Cardinal Health from $280.00 to $304.00 and gave the company a “buy” rating in a report on Monday, November 9th. One analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, Cardinal Health currently has an average rating of “Moderate Buy” and a consensus target price of $282.19.

Get Our Latest Report on CAH

Cardinal Health Stock Performance

Shares of CAH stock opened at $283.95 on Tuesday. Cardinal Health has a 1 year low of $180.45 and a 1 year high of $286.29. The stock has a fifty day moving average of $244.90 and a two-hundred day moving average of $225.61. The firm has a market capitalization of $65.63 billion, a PE ratio of 36.73, a price-to-earnings-growth ratio of 2.13 and a beta of 0.53.

Cardinal Health (NYSE:CAH – Get Free Report) last issued its quarterly earnings data on Thursday, November 5th. The company reported $3.26 earnings per share for the quarter, beating analysts’ consensus estimates of $2.94 by $0.32. The business had revenue of $67.51 billion for the quarter, compared to analysts’ expectations of $66.67 billion. Cardinal Health had a net margin of 0.71% and a negative return on equity of 102.72%. The company’s revenue was up 5.5% on a year-over-year basis. During the same period in the previous year, the business earned $2.55 earnings per share. Equities research analysts predict that Cardinal Health will post 12.97 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Cardinal Health news, CEO Jason Hollar sold 44,529 shares of the firm’s stock in a transaction that occurred on Wednesday, August 19th. The stock was sold at an average price of $236.18, for a total value of $10,516,859.22. Following the sale, the chief executive officer owned 190,603 shares of the company’s stock, valued at $45,016,616.54. This trade represents a 18.94% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CAO Mary C. Scherer sold 2,302 shares of the company’s stock in a transaction that occurred on Wednesday, August 19th. The shares were sold at an average price of $237.39, for a total value of $546,471.78. Following the completion of the transaction, the chief accounting officer directly owned 2,811 shares of the company’s stock, valued at approximately $667,303.29. This trade represents a 45.02% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.12% of the stock is owned by corporate insiders.

Institutional Trading of Cardinal Health

Several institutional investors and hedge funds have recently added to or reduced their stakes in CAH. Downshift Financial LLC boosted its position in shares of Cardinal Health by 3,666.7% in the 3rd quarter. Downshift Financial LLC now owns 113 shares of the company’s stock worth $25,000 after purchasing an additional 110 shares during the last quarter. Investors Research Corp bought a new position in Cardinal Health during the 2nd quarter worth approximately $29,000. Maryland Capital Advisors Inc. grew its holdings in Cardinal Health by 12,600.0% during the third quarter. Maryland Capital Advisors Inc. now owns 127 shares of the company’s stock valued at $28,000 after purchasing an additional 126 shares during the period. Allied Private Wealth LLC acquired a new stake in Cardinal Health in the second quarter worth $30,000. Finally, NBH Bank bought a new position in shares of Cardinal Health during the second quarter worth $31,000. 87.17% of the stock is owned by institutional investors.

Cardinal Health Company Profile

(Get Free Report)

Cardinal Health is a healthcare services and products company that distributes pharmaceuticals and medical supplies. Its customers include pharmacies, hospitals, surgery centers, physician offices and other healthcare providers. The company’s businesses include pharmaceutical distribution and specialty services, as well as the sourcing and distribution of medical and surgical products. Its offerings support areas such as specialty medications, medication management and supply-chain operations. Cardinal Health traces its roots to a wholesale business founded in Ohio in 1971 and later expanded into pharmaceutical distribution.

Featured Stories

Analyst Recommendations for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.